Acute Lymphoblastic Leukemia In The Adolescent and Young Adult: An Education Module For Clinical Trial, CALBG 10403

2.50
Hdl Handle:
http://hdl.handle.net/10755/165629
Category:
Abstract
Type:
Presentation
Title:
Acute Lymphoblastic Leukemia In The Adolescent and Young Adult: An Education Module For Clinical Trial, CALBG 10403
Author(s):
Haugen, Maureen; Toomey, Debbie; Byron, Patti
Author Details:
Maureen Haugen, RN, MS, CPNP, CPON, Pediatric Nurse Practitioner, Children's Memorial Hospital, Chicago, Illinois, USA, email: mhaugen@childrensmemorial.org; Debbie Toomey, MSN, PNP, CPON, City of Hope Medical Center, Duarte, California; Patti Byron, RN, MSN, British Columbia Childrens Hospital, Vancouver, Canada
Abstract:
Education: Clinical trial, CALGB 10403 was developed by the cooperative efforts of three adult oncology groups in response to the need to improve outcomes for adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL) being treated at adult institutions. The framework for this protocol is a current clinical trial for high risk pediatric patients through ChildrenÆs Oncology Group (COG), because recent research has shown that AYAs have improved survival if treated on a pediatric clinical trial. This protocol was open to enrollment in January 2008, therefore, the need for education became a priority. Education regarding this clinical trial was thought to be necessary because adult health care providers caring for AYAs with ALL are less familiar with components of this pediatric based regimen. The need for education was felt to be wide spread and immediate for physicians, nurses, pharmacists and research assistants. An educational module in webcast form for CALGB 10403 was created by the collaborative efforts of three adult oncology cooperative groups and led by members of the COG Nursing Discipline. This poster, which summarizes the information presented in the webcast, highlights the similarities and differences between treating a child versus and AYA patient with ALL, the phases of treatment, specific chemotherapy agents and side effects, as well as symptom management and late effects. One major component of the webcast is an evaluation form which will assess the effectiveness of this type of education in preparation for future collaborative efforts. The AYA age group is the least represented in clinical trials and accounts for only 10% of the population in either the adult or pediatric oncology setting. Unfortunately, many of these patients never make their way to a cancer or enroll on a clinical trial. This educational tool will help to promote this new protocol for AYAs with ALL, as well as provide information as to how to use it, thereby ultimately entering more patients on the treatment study and learning more about treating this unique patient population.
Repository Posting Date:
27-Oct-2011
Date of Publication:
27-Oct-2011
Conference Date:
2009
Conference Name:
34th Annual Oncology Nursing Society Congress
Conference Host:
Oncology Nursing Society
Conference Location:
San Antonio, Texas, USA
Note:
This is an abstract-only submission. If the author has submitted a full-text item based on this abstract, you may find it by browsing the Virginia Henderson Global Nursing e-Repository by author. If author contact information is available in this abstract, please feel free to contact him or her with your queries regarding this submission. Alternatively, please contact the conference host, journal, or publisher (according to the circumstance) for further details regarding this item. If a citation is listed in this record, the item has been published and is available via open-access avenues or a journal/database subscription. Contact your library for assistance in obtaining the as-published article.

Full metadata record

DC FieldValue Language
dc.type.categoryAbstracten_US
dc.typePresentationen_GB
dc.titleAcute Lymphoblastic Leukemia In The Adolescent and Young Adult: An Education Module For Clinical Trial, CALBG 10403en_GB
dc.contributor.authorHaugen, Maureenen_US
dc.contributor.authorToomey, Debbieen_US
dc.contributor.authorByron, Pattien_US
dc.author.detailsMaureen Haugen, RN, MS, CPNP, CPON, Pediatric Nurse Practitioner, Children's Memorial Hospital, Chicago, Illinois, USA, email: mhaugen@childrensmemorial.org; Debbie Toomey, MSN, PNP, CPON, City of Hope Medical Center, Duarte, California; Patti Byron, RN, MSN, British Columbia Childrens Hospital, Vancouver, Canadaen_US
dc.identifier.urihttp://hdl.handle.net/10755/165629-
dc.description.abstractEducation: Clinical trial, CALGB 10403 was developed by the cooperative efforts of three adult oncology groups in response to the need to improve outcomes for adolescents and young adults (AYAs) with acute lymphoblastic leukemia (ALL) being treated at adult institutions. The framework for this protocol is a current clinical trial for high risk pediatric patients through ChildrenÆs Oncology Group (COG), because recent research has shown that AYAs have improved survival if treated on a pediatric clinical trial. This protocol was open to enrollment in January 2008, therefore, the need for education became a priority. Education regarding this clinical trial was thought to be necessary because adult health care providers caring for AYAs with ALL are less familiar with components of this pediatric based regimen. The need for education was felt to be wide spread and immediate for physicians, nurses, pharmacists and research assistants. An educational module in webcast form for CALGB 10403 was created by the collaborative efforts of three adult oncology cooperative groups and led by members of the COG Nursing Discipline. This poster, which summarizes the information presented in the webcast, highlights the similarities and differences between treating a child versus and AYA patient with ALL, the phases of treatment, specific chemotherapy agents and side effects, as well as symptom management and late effects. One major component of the webcast is an evaluation form which will assess the effectiveness of this type of education in preparation for future collaborative efforts. The AYA age group is the least represented in clinical trials and accounts for only 10% of the population in either the adult or pediatric oncology setting. Unfortunately, many of these patients never make their way to a cancer or enroll on a clinical trial. This educational tool will help to promote this new protocol for AYAs with ALL, as well as provide information as to how to use it, thereby ultimately entering more patients on the treatment study and learning more about treating this unique patient population.en_GB
dc.date.available2011-10-27T12:22:07Z-
dc.date.issued2011-10-27en_GB
dc.date.accessioned2011-10-27T12:22:07Z-
dc.conference.date2009en_US
dc.conference.name34th Annual Oncology Nursing Society Congressen_US
dc.conference.hostOncology Nursing Societyen_US
dc.conference.locationSan Antonio, Texas, USAen_US
dc.description.noteThis is an abstract-only submission. If the author has submitted a full-text item based on this abstract, you may find it by browsing the Virginia Henderson Global Nursing e-Repository by author. If author contact information is available in this abstract, please feel free to contact him or her with your queries regarding this submission. Alternatively, please contact the conference host, journal, or publisher (according to the circumstance) for further details regarding this item. If a citation is listed in this record, the item has been published and is available via open-access avenues or a journal/database subscription. Contact your library for assistance in obtaining the as-published article.-
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.